These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6693894)

  • 1. Passive transfer of Lambert-Eaton myasthenic syndrome in mice: decreased rates of resting and evoked release of acetylcholine from skeletal muscle.
    Lang B; Molenaar PC; Newsom-Davis J; Vincent A
    J Neurochem; 1984 Mar; 42(3):658-62. PubMed ID: 6693894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Passive transfer of Lambert-Eaton syndrome to mice induces dihydropyridine sensitivity of neuromuscular transmission.
    Flink MT; Atchison WD
    J Physiol; 2002 Sep; 543(Pt 2):567-76. PubMed ID: 12205190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Passive transfer of Lambert-Eaton myasthenic syndrome with IgG from man to mouse depletes the presynaptic membrane active zones.
    Fukunaga H; Engel AG; Lang B; Newsom-Davis J; Vincent A
    Proc Natl Acad Sci U S A; 1983 Dec; 80(24):7636-40. PubMed ID: 6584877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surplus acetylcholine and acetylcholine release in the rat diaphragm.
    Molenaar PC; Oen BS; Polak RL; van der Laaken AL
    J Physiol; 1987 Apr; 385():147-67. PubMed ID: 3498823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eaton-Lambert syndrome: acetylcholine and choline acetyltransferase in skeletal muscle.
    Molenaar PC; Newsom-Davis J; Polak RL; Vincent A
    Neurology; 1982 Sep; 32(9):1061-5. PubMed ID: 6287358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presynaptic effects of immunoglobulin G from patients with Lambert-Eaton myasthenic syndrome: their neutralization by intravenous immunoglobulins.
    Buchwald B; Ahangari R; Weishaupt A; Toyka KV
    Muscle Nerve; 2005 Apr; 31(4):487-94. PubMed ID: 15685615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Action of Lambert-Eaton myasthenic syndrome IgG at mouse motor nerve terminals.
    Prior C; Lang B; Wray D; Newsom-Davis J
    Ann Neurol; 1985 Jun; 17(6):587-92. PubMed ID: 2992356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lambert-Eaton myasthenic syndrome: immunoglobulin G inhibition of Ca2+ flux in tumor cells correlates with disease severity.
    Lang B; Vincent A; Murray NM; Newsom-Davis J
    Ann Neurol; 1989 Mar; 25(3):265-71. PubMed ID: 2543262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Lambert-Eaton myasthenic syndrome antibodies on autonomic neurons in the mouse.
    Waterman SA; Lang B; Newsom-Davis J
    Ann Neurol; 1997 Aug; 42(2):147-56. PubMed ID: 9266723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lambert-Eaton myasthenic syndrome.
    Newsom-Davis J
    Springer Semin Immunopathol; 1985; 8(1-2):129-40. PubMed ID: 2988146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specificity of Lambert-Eaton myasthenic syndrome immunoglobulin for nerve terminal calcium channels.
    Hewett SJ; Atchison WD
    Brain Res; 1992 Dec; 599(2):324-32. PubMed ID: 1363289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Passive transfer of the Lambert-Eaton myasthenic syndrome: neuromuscular transmission in mice injected with plasma.
    Kim YI
    Muscle Nerve; 1985 Feb; 8(2):162-72. PubMed ID: 2997605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lambert-Eaton myasthenic syndrome IgG depletes presynaptic membrane active zone particles by antigenic modulation.
    Nagel A; Engel AG; Lang B; Newsom-Davis J; Fukuoka T
    Ann Neurol; 1988 Oct; 24(4):552-8. PubMed ID: 2853605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lambert-Eaton myasthenic syndrome: a review.
    Newsom-Davis J
    Monogr Allergy; 1988; 25():116-24. PubMed ID: 2845259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evoked acetylcholine release by immortalized brain endothelial cells genetically modified to express choline acetyltransferase and/or the vesicular acetylcholine transporter.
    Malo M; Diebler MF; Prado de Carvalho L; Meunier FM; Dunant Y; Bloc A; Stinnakre J; Tomasi M; Tchélingérian J; Couraud PO; Israël M
    J Neurochem; 1999 Oct; 73(4):1483-91. PubMed ID: 10501193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium channel subtypes contributing to acetylcholine release from normal, 4-aminopyridine-treated and myasthenic syndrome auto-antibodies-affected neuromuscular junctions.
    Giovannini F; Sher E; Webster R; Boot J; Lang B
    Br J Pharmacol; 2002 Aug; 136(8):1135-45. PubMed ID: 12163346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lambert-Eaton myasthenic syndrome: search for alternative autoimmune targets and possible compensatory mechanisms based on presynaptic calcium homeostasis.
    Takamori M
    J Neuroimmunol; 2008 Sep; 201-202():145-52. PubMed ID: 18653248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recovery of acetylcholine release and choline acetyltransferase activity after freezing-induced degeneration of rat soleus muscle.
    Van Kempen GT; Molenaar PC
    Neurochem Int; 1998; 32(5-6):443-7. PubMed ID: 9676743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lambert-Eaton syndrome antibodies inhibit acetylcholine release and P/Q-type Ca2+ channels in electric ray nerve endings.
    Satoh Y; Hirashima N; Tokumaru H; Takahashi MP; Kang J; Viglione MP; Kim YI; Kirino Y
    J Physiol; 1998 Apr; 508 ( Pt 2)(Pt 2):427-38. PubMed ID: 9508807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of Lambert-Eaton myasthenic syndrome antibody on slow action potentials in mouse cardiac ventricle.
    Lang B; Newsom-Davis J; Wray DW
    Proc R Soc Lond B Biol Sci; 1988 Oct; 235(1278):103-10. PubMed ID: 2907138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.